Title:
NOVEL ANTI-CD4 AND ANTI-PD-L1 BISPECIFIC ANTIBODIES
Document Type and Number:
WIPO Patent Application WO/2023/143478
Kind Code:
A1
Abstract:
Provided are anti-CD4 and anti-PD-L1 bispecific antibodies or antigen-binding fragments thereof, isolated polynucleotides encoding the same, pharmaceutical compositions comprising the same, and the uses thereof.
Inventors:
WERY JEAN PIERRE (US)
NIU QIAN (US)
SUN ZIYONG (US)
LIU YUNPING (CN)
QIAN YONGYU (CN)
WANG CHENGCHENG (CN)
NIU QIAN (US)
SUN ZIYONG (US)
LIU YUNPING (CN)
QIAN YONGYU (CN)
WANG CHENGCHENG (CN)
Application Number:
PCT/CN2023/073491
Publication Date:
August 03, 2023
Filing Date:
January 27, 2023
Export Citation:
Assignee:
CROWN BIOSCIENCE INC (US)
CROWN BIOSCIENCE INC TAICANG (CN)
CROWN BIOSCIENCE INC TAICANG (CN)
International Classes:
C07K16/28; A61K39/395; A61P35/00; C12N15/13
Domestic Patent References:
| WO2021025140A1 | 2021-02-11 | |||
| WO2021195067A1 | 2021-09-30 |
Foreign References:
| CN113045661A | 2021-06-29 | |||
| CN111918876A | 2020-11-10 | |||
| US20200048358A1 | 2020-02-13 | |||
| US20100203056A1 | 2010-08-12 | |||
| US20200347146A1 | 2020-11-05 |
Attorney, Agent or Firm:
JUN HE LAW OFFICES (CN)
Download PDF:
Previous Patent: COSMETIC LINER AND COMPOSITE CONTAINER
Next Patent: SMALL RNA AND USE THEREOF IN TREATMENT OF HYPERLIPIDEMIA
Next Patent: SMALL RNA AND USE THEREOF IN TREATMENT OF HYPERLIPIDEMIA